Imatinib use in chronic phase CML in clinical practice: the UNIC study

Autor:	Enrica Morra, David Marin, Mauricette Michallet, Gregor Verhoef, M. Björeman, Juan Luis Steegmann, K. Cerri, T. Kühr, M. Sterckx, Gert J. Ossenkoppele
Rok vydání:	2008
Předmět:	Cancer Research medicine.medical_specialty Pediatrics business.industry Alternative medicine Imatinib Unmet needs Clinical Practice Oncology hemic and lymphatic diseases Chart review medicine Chronic phase CML business neoplasms medicine.drug
Zdroj:	Journal of Clinical Oncology. 26:7077-7077
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2008.26.15_suppl.7077
Popis:	7077 Background: Imatinib (IM) is widely used to treat CML. The Unmet Needs in CML study assessed real-life treatment of CML. Methods: This cross-sectional study, with retrospective chart review of...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fb9ab9c89f5003f6daf11c75c957a64a https://doi.org/10.1200/jco.2008.26.15_suppl.7077 Zobrazit plný text záznamu